Zenomics

Zenomics is developing a microneedle transdermal patch technology for diabetes that can sense blood glucose levels and respond with an appropriate concentration of insulin. The company's drug delivery patch can sense blood glucose levels and respond with an appropriate concentration of insulin. Founded in 2015, the company is headquartered in North Carolina.